APO RESEARCH · REPORT
Medical Isotopes
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
Product & engineering
Understand the product.
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
Selected research
Market Structure
Global Medical Isotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.
In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.
Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an example of a product sterilised by gamma rays. Because it is a 'cold' process radiation can be used to sterilise a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilisation are installed in many countries. Smaller gamma irradiators, often utilising Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilisation by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilised by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.
Read the full market overview
North America is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 15% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990’s other governments began to view the isotope industry as a high tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.
Report Includes
This report provides an overview of the global Medical Isotopes market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Isotopes and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Isotopes revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medical Isotopes market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Isotopes Segment by Company
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
ORNL
SI Science
Medical Isotopes Segment by Type
Stable Isotopes
Radioisotopes
Medical Isotopes Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Medical Isotopes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Isotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Isotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Isotopes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medical Isotopes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Isotopes industry.
Chapter 3: Detailed analysis of Medical Isotopes companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Isotopesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Stable Isotopes
- Radioisotopes
Applications
- Nuclear Therapy
- Equipment Radioactive Source
- Diagnosis
Companies covered
- NRG
- NTP Radioisotopes
- JSC Isotope
- ANSTO
- IRE
- Nordion
- Curium Pharma
- Cambridge Isotope Laboratories
- Eckert & Ziegler Strahlen
- Polatom
- Center of Molecular Research
- China National Nuclear Corporation
- Urenco
- LANL
- Shanghai Engineering Research Center
- IDB Holland
- NHTC
- Linde
- ORNL
- SI Science
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Medical Isotopes Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Stable Isotopes
- 1.2.3 Radioisotopes
- 1.3 Market Analysis by Application
- 1.3.1 Global Medical Isotopes Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Nuclear Therapy
- 1.3.3 Equipment Radioactive Source
- 1.3.4 Diagnosis
- 1.4 Global Market Growth Prospects
- 1.5 Global Medical Isotopes Growth Trends by Region
- 1.5.1 Global Medical Isotopes Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Medical Isotopes Market Size by Region (2021-2026)
- 1.5.3 Medical Isotopes Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Medical Isotopes Market Dynamics
- 2.1 Medical Isotopes Industry Trends
- 2.2 Medical Isotopes Industry Drivers
- 2.3 Medical Isotopes Industry Opportunities and Challenges
- 2.4 Medical Isotopes Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Medical Isotopes Revenue by Company (2021-2026)
- 3.2 Global Medical Isotopes Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Medical Isotopes Key Company Head office and Area Served
- 3.4 Global Medical Isotopes Company, Product Type & Application
- 3.5 Global Medical Isotopes Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Medical Isotopes Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Medical Isotopes Players Market Share by Revenue in 2025
- 3.6.3 2025 Medical Isotopes Tier 1, Tier 2, and Tier 3
4 Medical Isotopes Market by Type
- 4.1 Global Medical Isotopes Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Medical Isotopes Market Size by Type (2021-2032)
- 4.3 Global Medical Isotopes Market Size Share by Type (2021-2032)
5 Medical Isotopes Market by Application
- 5.1 Global Medical Isotopes Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Medical Isotopes Market Size by Application (2021-2032)
- 5.3 Global Medical Isotopes Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 NRG
- 6.1.1 NRG Company Information
- 6.1.2 NRG Business Overview
- 6.1.3 NRG Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 NRG Medical Isotopes Product Portfolio
- 6.1.5 NRG Recent Developments
- 6.2 NTP Radioisotopes
- 6.2.1 NTP Radioisotopes Company Information
- 6.2.2 NTP Radioisotopes Business Overview
- 6.2.3 NTP Radioisotopes Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 NTP Radioisotopes Medical Isotopes Product Portfolio
- 6.2.5 NTP Radioisotopes Recent Developments
- 6.3 JSC Isotope
- 6.3.1 JSC Isotope Company Information
- 6.3.2 JSC Isotope Business Overview
- 6.3.3 JSC Isotope Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 JSC Isotope Medical Isotopes Product Portfolio
- 6.3.5 JSC Isotope Recent Developments
- 6.4 ANSTO
- 6.4.1 ANSTO Company Information
- 6.4.2 ANSTO Business Overview
- 6.4.3 ANSTO Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 ANSTO Medical Isotopes Product Portfolio
- 6.4.5 ANSTO Recent Developments
- 6.5 IRE
- 6.5.1 IRE Company Information
- 6.5.2 IRE Business Overview
- 6.5.3 IRE Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 IRE Medical Isotopes Product Portfolio
- 6.5.5 IRE Recent Developments
- 6.6 Nordion
- 6.6.1 Nordion Company Information
- 6.6.2 Nordion Business Overview
- 6.6.3 Nordion Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Nordion Medical Isotopes Product Portfolio
- 6.6.5 Nordion Recent Developments
- 6.7 Curium Pharma
- 6.7.1 Curium Pharma Company Information
- 6.7.2 Curium Pharma Business Overview
- 6.7.3 Curium Pharma Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Curium Pharma Medical Isotopes Product Portfolio
- 6.7.5 Curium Pharma Recent Developments
- 6.8 Cambridge Isotope Laboratories
- 6.8.1 Cambridge Isotope Laboratories Company Information
- 6.8.2 Cambridge Isotope Laboratories Business Overview
- 6.8.3 Cambridge Isotope Laboratories Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Cambridge Isotope Laboratories Medical Isotopes Product Portfolio
- 6.8.5 Cambridge Isotope Laboratories Recent Developments
- 6.9 Eckert & Ziegler Strahlen
- 6.9.1 Eckert & Ziegler Strahlen Company Information
- 6.9.2 Eckert & Ziegler Strahlen Business Overview
- 6.9.3 Eckert & Ziegler Strahlen Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Eckert & Ziegler Strahlen Medical Isotopes Product Portfolio
- 6.9.5 Eckert & Ziegler Strahlen Recent Developments
- 6.10 Polatom
- 6.10.1 Polatom Company Information
- 6.10.2 Polatom Business Overview
- 6.10.3 Polatom Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Polatom Medical Isotopes Product Portfolio
- 6.10.5 Polatom Recent Developments
- 6.11 Center of Molecular Research
- 6.11.1 Center of Molecular Research Company Information
- 6.11.2 Center of Molecular Research Business Overview
- 6.11.3 Center of Molecular Research Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Center of Molecular Research Medical Isotopes Product Portfolio
- 6.11.5 Center of Molecular Research Recent Developments
- 6.12 China National Nuclear Corporation
- 6.12.1 China National Nuclear Corporation Company Information
- 6.12.2 China National Nuclear Corporation Business Overview
- 6.12.3 China National Nuclear Corporation Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 China National Nuclear Corporation Medical Isotopes Product Portfolio
- 6.12.5 China National Nuclear Corporation Recent Developments
- 6.13 Urenco
- 6.13.1 Urenco Company Information
- 6.13.2 Urenco Business Overview
- 6.13.3 Urenco Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Urenco Medical Isotopes Product Portfolio
- 6.13.5 Urenco Recent Developments
- 6.14 LANL
- 6.14.1 LANL Company Information
- 6.14.2 LANL Business Overview
- 6.14.3 LANL Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 LANL Medical Isotopes Product Portfolio
- 6.14.5 LANL Recent Developments
- 6.15 Shanghai Engineering Research Center
- 6.15.1 Shanghai Engineering Research Center Company Information
- 6.15.2 Shanghai Engineering Research Center Business Overview
- 6.15.3 Shanghai Engineering Research Center Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Shanghai Engineering Research Center Medical Isotopes Product Portfolio
- 6.15.5 Shanghai Engineering Research Center Recent Developments
- 6.16 IDB Holland
- 6.16.1 IDB Holland Company Information
- 6.16.2 IDB Holland Business Overview
- 6.16.3 IDB Holland Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 IDB Holland Medical Isotopes Product Portfolio
- 6.16.5 IDB Holland Recent Developments
- 6.17 NHTC
- 6.17.1 NHTC Company Information
- 6.17.2 NHTC Business Overview
- 6.17.3 NHTC Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 NHTC Medical Isotopes Product Portfolio
- 6.17.5 NHTC Recent Developments
- 6.18 Linde
- 6.18.1 Linde Company Information
- 6.18.2 Linde Business Overview
- 6.18.3 Linde Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Linde Medical Isotopes Product Portfolio
- 6.18.5 Linde Recent Developments
- 6.19 ORNL
- 6.19.1 ORNL Company Information
- 6.19.2 ORNL Business Overview
- 6.19.3 ORNL Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 ORNL Medical Isotopes Product Portfolio
- 6.19.5 ORNL Recent Developments
- 6.20 SI Science
- 6.20.1 SI Science Company Information
- 6.20.2 SI Science Business Overview
- 6.20.3 SI Science Medical Isotopes Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 SI Science Medical Isotopes Product Portfolio
- 6.20.5 SI Science Recent Developments
7 North America
- 7.1 North America Medical Isotopes Market Size (2021-2032)
- 7.2 North America Medical Isotopes Market Size by Type
- 7.2.1 North America Medical Isotopes Market Size by Type (2021-2026)
- 7.2.2 North America Medical Isotopes Market Size by Type (2027-2032)
- 7.2.3 North America Medical Isotopes Market Share by Type (2021-2032)
- 7.3 North America Medical Isotopes Market Size by Application
- 7.3.1 North America Medical Isotopes Market Size by Application (2021-2026)
- 7.3.2 North America Medical Isotopes Market Size by Application (2027-2032)
- 7.3.3 North America Medical Isotopes Market Share by Application (2021-2032)
- 7.4 North America Medical Isotopes Market Size by Country
- 7.4.1 North America Medical Isotopes Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Medical Isotopes Market Size by Country (2021-2026)
- 7.4.3 North America Medical Isotopes Market Size by Country (2027-2032)
- 7.4.4 North America Medical Isotopes Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Medical Isotopes Market Size (2021-2032)
- 8.2 Europe Medical Isotopes Market Size by Type
- 8.2.1 Europe Medical Isotopes Market Size by Type (2021-2026)
- 8.2.2 Europe Medical Isotopes Market Size by Type (2027-2032)
- 8.2.3 Europe Medical Isotopes Market Share by Type (2021-2032)
- 8.3 Europe Medical Isotopes Market Size by Application
- 8.3.1 Europe Medical Isotopes Market Size by Application (2021-2026)
- 8.3.2 Europe Medical Isotopes Market Size by Application (2027-2032)
- 8.3.3 Europe Medical Isotopes Market Share by Application (2021-2032)
- 8.4 Europe Medical Isotopes Market Size by Country
- 8.4.1 Europe Medical Isotopes Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Medical Isotopes Market Size by Country (2021-2026)
- 8.4.3 Europe Medical Isotopes Market Size by Country (2027-2032)
- 8.4.4 Europe Medical Isotopes Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Medical Isotopes Market Size (2021-2032)
- 9.2 China Medical Isotopes Market Size by Type
- 9.2.1 China Medical Isotopes Market Size by Type (2021-2026)
- 9.2.2 China Medical Isotopes Market Size by Type (2027-2032)
- 9.2.3 China Medical Isotopes Market Share by Type (2021-2032)
- 9.3 China Medical Isotopes Market Size by Application
- 9.3.1 China Medical Isotopes Market Size by Application (2021-2026)
- 9.3.2 China Medical Isotopes Market Size by Application (2027-2032)
- 9.3.3 China Medical Isotopes Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Medical Isotopes Market Size (2021-2032)
- 10.2 Asia Medical Isotopes Market Size by Type
- 10.2.1 Asia Medical Isotopes Market Size by Type (2021-2026)
- 10.2.2 Asia Medical Isotopes Market Size by Type (2027-2032)
- 10.2.3 Asia Medical Isotopes Market Share by Type (2021-2032)
- 10.3 Asia Medical Isotopes Market Size by Application
- 10.3.1 Asia Medical Isotopes Market Size by Application (2021-2026)
- 10.3.2 Asia Medical Isotopes Market Size by Application (2027-2032)
- 10.3.3 Asia Medical Isotopes Market Share by Application (2021-2032)
- 10.4 Asia Medical Isotopes Market Size by Country
- 10.4.1 Asia Medical Isotopes Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Medical Isotopes Market Size by Country (2021-2026)
- 10.4.3 Asia Medical Isotopes Market Size by Country (2027-2032)
- 10.4.4 Asia Medical Isotopes Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Medical Isotopes Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Medical Isotopes Market Size by Type
- 11.2.1 South America, Middle East & Africa Medical Isotopes Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Medical Isotopes Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Medical Isotopes Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Medical Isotopes Market Size by Application
- 11.3.1 South America, Middle East & Africa Medical Isotopes Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Medical Isotopes Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Medical Isotopes Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Medical Isotopes Market Size by Country
- 11.4.1 South America, Middle East & Africa Medical Isotopes Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Medical Isotopes Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Medical Isotopes Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Medical Isotopes Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst